TY  - GEN
AU  - Scott,David L
AU  - Cope,Andrew
TI  - New tumour necrosis factor inhibitors for rheumatoid arthritis: are there benefits from extending choice?
SN  - 1468-2060
PY  - 2009///0624
KW  - Anti-Inflammatory Agents
KW  - economics
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Arthritis, Rheumatoid
KW  - drug therapy
KW  - Certolizumab Pegol
KW  - Cost-Benefit Analysis
KW  - Humans
KW  - Immunoglobulin Fab Fragments
KW  - Patient Selection
KW  - Polyethylene Glycols
KW  - Randomized Controlled Trials as Topic
KW  - Treatment Outcome
KW  - Tumor Necrosis Factor-alpha
KW  - antagonists & inhibitors
N1  - Publication Type: Editorial; Comment
UR  - https://doi.org/10.1136/ard.2008.105940
ER  -